Safety and feasibility of levosimendan administration in takotsubo cardiomyopathy: a case series.
about
Takotsubo cardiomyopathy and its relevance to anesthesiology: a narrative review.Lack of efficacy of drug therapy in preventing takotsubo cardiomyopathy recurrence: a meta-analysis.Nonatherosclerotic causes of acute coronary syndrome: recognition and management.Current state of knowledge on Takotsubo syndrome: a Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology.Improving the understanding of Takotsubo syndrome: consequences of diagnosis and treatment.Therapy of stress (takotsubo) cardiomyopathy: present shortcomings and future perspectives.Takotsubo Cardiomyopathy in Traumatic Brain Injury.Levosimendan, a new therapeutic approach to prevent delayed cerebral vasospasm after subarachnoid hemorrhage?[Levosimendan for septic shock with takotsubo cardiomyopathy].Carbohydrate-antigen-125 levels predict hospital stay duration and adverse events at long-term follow-up in Takotsubo cardiomyopathy.Incidence, determinants and prognostic relevance of cardiogenic shock in patients with Takotsubo cardiomyopathy.Incidence and Prognostic Relevance of Cardiopulmonary Failure in Takotsubo Cardiomyopathy.Impact and management of left ventricular function on the prognosis of Takotsubo syndrome.Anesthetic management of a patient with Takotsubo cardiomyopathy presenting for surgical clipping of intracranial aneurysm.Epidemiology, pathogenesis, and management of takotsubo syndrome.Takotsubo syndrome.International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management.
P2860
Q30249480-98B8CA77-370B-4896-B609-F2A43E2234BCQ38202072-1E0FAD25-4FEC-41AB-B3D7-6F9AD2173312Q38259447-2A29610D-C355-443C-B882-9A001EC9D78FQ38628159-E3D7BB97-7D40-44EA-933A-377AE2C90B01Q38721501-FA9BDCA4-E872-440B-A33C-67A4E0278207Q38830075-29EF7EDD-EC31-410E-AC0D-7D2D6AE50233Q39045144-47749C1E-F8F6-4660-A355-A4A83C8C8EA0Q39403989-1DBFE57F-8DDF-4E6C-9170-D4F0DAC24402Q40889719-B80D7BC3-35D9-48D3-82E5-FED080E25921Q40937468-36CB91AA-0FAF-40B4-8436-5F1782971F81Q41208455-31F71869-545D-42F5-B284-D132585DCF4CQ44234564-69DF282C-1379-4277-9F5B-6C5A2014E49DQ47888067-C552E451-4B0A-4BFD-8455-CAA96D6D76B9Q49231121-035478BE-6F3F-4683-9C8C-D72E0BC5E4AAQ49883620-D6F8C173-8666-40C0-B7EB-62DF7DB4CB52Q49887636-918A434C-CB74-48D0-9A4B-C97A772E270EQ55404181-8F72A06C-CF4E-4422-83DA-A740B8DA158C
P2860
Safety and feasibility of levosimendan administration in takotsubo cardiomyopathy: a case series.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Safety and feasibility of levo ...... cardiomyopathy: a case series.
@en
Safety and feasibility of levo ...... cardiomyopathy: a case series.
@nl
type
label
Safety and feasibility of levo ...... cardiomyopathy: a case series.
@en
Safety and feasibility of levo ...... cardiomyopathy: a case series.
@nl
prefLabel
Safety and feasibility of levo ...... cardiomyopathy: a case series.
@en
Safety and feasibility of levo ...... cardiomyopathy: a case series.
@nl
P2093
P2860
P50
P356
P1476
Safety and feasibility of levo ...... cardiomyopathy: a case series.
@en
P2093
Giuseppe Carpagnano
Luigi Di Biase
Matteo Di Biase
Michele Lodispoto
Riccardo Ieva
Vincenzo Ienco
P2860
P304
P356
10.1111/1755-5922.12047
P577
2013-12-01T00:00:00Z